Leptomeningeal Metastases

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2012-11-09
Clinical Trial Update: Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease [NA]
A clinical trial evaluating continuous intraventricular methotrexate for leptomeningeal metastases has been withdrawn.